Steward Partners Investment Advisory’s PDL BioPharma, Inc. PDLI Stock Holding History

Steward Partners Investment Advisory’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-235	Closed	-$1K	–	2595
2018 Q3	$1K	Hold	235	–	–	﹤0.01%	2573
2018 Q2	$1K	Hold	235	–	–	﹤0.01%	2432
2018 Q1	$0	Hold	235	–	–	﹤0.01%	2429
2017 Q4	$0	Hold	235	–	–	﹤0.01%	2028
2017 Q3	$0	Sell	235 -234	-50%	-$651	﹤0.01%	1842
2017 Q2	$1K	Hold	469	–	–	﹤0.01%	1593
2017 Q1	$1K	Hold	469	–	–	﹤0.01%	1480
2016 Q4	$0	Buy	+469	New	+$1.31K	﹤0.01%	926

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Steward Partners Investment Advisory's PDLI Position: Q4 2018 in Review

Steward Partners Investment Advisory sold out of PDL BioPharma, Inc. (PDLI) in Q4 2018, closing a stake of 235 shares — an estimated $1K sold.

Steward Partners Investment Advisory first reported a position in PDLI in Q4 2016 and held it in 8 quarters. The position peaked at $1K in Q3 2018. 154 funds tracked by Wall St. Rank hold PDLI as of Q4 2018.

Steward Partners Investment Advisory reported no remaining PDL BioPharma, Inc. position as of Q4 2018 after selling out during the quarter.
Steward Partners Investment Advisory sold 235 PDL BioPharma, Inc. shares in Q4 2018, an estimated $1K.
Steward Partners Investment Advisory first reported a position in PDL BioPharma, Inc. in Q4 2016 and held it in 8 quarters.
Steward Partners Investment Advisory's PDL BioPharma, Inc. position peaked at $1K in Q3 2018.
154 funds tracked by Wall St. Rank held PDL BioPharma, Inc. as of Q4 2018.

Based on Steward Partners Investment Advisory's 13F filing for Q4 2018, filed 15 Jan 2019.